Omicron Mass Surge: The Silver Lining & Concerning Indications for Children & Elderly

What makes a variant a new strain? What makes a new disease, such as Covid-19 versus Covid-21? Well, much of it turns out to be semantics. What is supposed to classify a new strain is a significant change in a virus' behavior in relation to pathogenicity, immunogenicity, transmissibility, and/or virulence. So, is Omicron just another variant? 

Let's look a little closer at its traits compared to previous variants in these critical areas:

1. Pathogenicity - there is convincing data that Omicron does indeed possess a dramatic change in pathogenicity.  Multiple animal models evidence that Omicron infects the bronchi tissue much more efficiently (7000%), and infects the lung cells much less efficiently (-3000%) than Delta.

Omicron appears to not need or use the transmembrane protease, TMPRSS2 for Spike protein priming or cell membrane fusion. Another major divergence in pathogenicity is that Omicron no longer exhibits cell to cell fusion via syncytia. It exclusively infects via the ACE2 endocytosis pathway.

2. Immunogenicity - It's recently been shown that Omicron generates robust immunity against the prior VOC, Delta.   However, t...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee